LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Charles River Laboratories (NYSE: CRL)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSE CRL Charles River Laboratories
Knell Michael Gunnar / officer: CSVP, CAO, Interim CFO
11/06/2025
Buy
$170.88
2,926
$500K
13,460